| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 10/04/2006 | CN1839823A Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
| 10/04/2006 | CN1839817A Anticancer slow release injection containing taxone |
| 10/04/2006 | CN1839806A Methods for in vivo delivery of biologics and compositions useful therefor |
| 10/04/2006 | CN1277840C Growth hormone releasing compound for treating tumor and inhibitor thereof |
| 10/04/2006 | CN1277828C Piperzine derivative |
| 10/04/2006 | CN1277541C Use of ATase inhibitor in preparing synergistic pharmaceutical composition for human cancer cell toxicity |
| 10/04/2006 | CN1277535C Ibuprofen active agent preparation |
| 10/03/2006 | US7115777 For therapy of hypertension, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, complications resulting from diabetes, such as nephropathy, vasculopathy and neuropathy, diseases of the coronary vessels, restenosis following angioplasty |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115663 Increased or improved bioavailability of the active agent |
| 10/03/2006 | US7115656 Administering cocoa extracts including procyanidin monomers and oligomers to treat inflammation, atherosclerosis, and cardiovascular disorders; bactericides, foods; cyclooxygenase and/or lipoxygenase inhibitors |
| 10/03/2006 | US7115650 Administering a composition comprising an inhibitor of dipeptidyl peptidase IV; (2S)-N-isoleucylpyrrolidine-2-carbonitrile; (2S)-N-((2'S)-2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile |
| 10/03/2006 | US7115631 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 10/03/2006 | US7115628 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction |
| 10/03/2006 | US7115626 Treatment of cardiovascular and related pathologies |
| 10/03/2006 | US7115625 Administering mixtures of pyridoxal-5'-phosphate, pyridoxal, pyridoxamine, and analogues, angiotensin converting enzyme inhibitors, angiotensin receptor antagonists, vasodilators and diuretics, for prophylaxis of congestive heart failure |
| 10/03/2006 | US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties |
| 10/03/2006 | US7115606 2-(1-piperazinyl) thieno[2,3-d]pyrimidine derivatives having 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity; nocturia or overactive bladder |
| 10/03/2006 | US7115599 Guanylate cyclase stimulant; cardiovascular disorders; thrombosis; antiischemic agents; sexual disorders; antiinflammatory agents; central nervous system disorders |
| 10/03/2006 | US7115597 Tyrosine kinase inhibitors |
| 10/03/2006 | US7115590 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents |
| 10/03/2006 | US7115586 Non-inclusion cyclodextrin complexes |
| 10/03/2006 | US7115584 HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine |
| 10/03/2006 | US7115569 Exendins, exendin agonists, and methods for their use |
| 10/03/2006 | US7115565 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| 10/03/2006 | US7115563 vitamin; a metal salt that provides metal ions in vivo; and insulin or a growth hormone |
| 10/03/2006 | US7115559 Administering factor XIII to patients afflicted with bleeding due to a coumarin anticoagulant-induced vitamin K deficiency |
| 10/03/2006 | US7115554 Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| 10/03/2006 | US7115414 Comprises nucleotide sequences coding transmembrane protein/transport protein (TRPV3) for treating pain, inflammation and skin disorders |
| 10/03/2006 | US7115398 Nucleotide sequences coding polypeptide for use in the treatment of bone disorders |
| 10/03/2006 | US7115395 DNAs encoding guinea pig histamine receptors of the H4 subtype |
| 10/03/2006 | US7115380 Applications of peptides derived from the cytoplasmic domain of amyloid precursor protein (APP) |
| 10/03/2006 | US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 10/03/2006 | US7115297 Shelf-stable, ready to use; to enhance delivery of active medicants/ingredients of pharmaceuticals, nutraceuticals, dietary supplements, therapeutics, diagnostics |
| 10/03/2006 | US7115279 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 10/03/2006 | US7115278 Proteoglycan compositions for the treatment of cardiovascular inflammatory diseases |
| 10/03/2006 | US7115263 Compositions and methods for treating hyperimmune response in the eye |
| 10/03/2006 | US7115261 Combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target. |
| 10/03/2006 | US7115260 Interleukin-1β converting enzyme like apoptotic protease-6 |
| 10/03/2006 | US7115259 Removing peripheral blood mononuclear cells; treating to generate regulatory T cells comprising anti-CD2 and anti-CD3; reintroducing |
| 10/03/2006 | US7115253 Stabilizing levogyrous acid or proanthocyanidines by contacting with a glycol oxygen-removing compound, a hydroxyethylidenediphosphonic acid, ethylenediamine- or diethylenetriamine- methane phosphonic acid or a sodium salt of the acids as a metallic ion sequestering compound, and a reducing agent |
| 10/03/2006 | US7115252 For restoration and maintenance of gingival and periodontal health; antiplaque/antitar agents; mouthwash |
| 10/03/2006 | US7115250 Heating erectile dysfunction drug to vaporize; cooling to form condensation aerosol; drug delivery |
| 10/03/2006 | US7114966 Apparatus for a quick release safety connector assembly |
| 10/03/2006 | CA2489834C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 10/03/2006 | CA2277018C Use of angiotensin ii antagonists to treat symptomatic heart failure |
| 10/03/2006 | CA2261879C Aerosol formulations |
| 10/03/2006 | CA2251840C Composition, barrier film, and method for preventing contact dermatitis |
| 10/03/2006 | CA2250906C Enteric-coated pharmaceutical compositions of mycophenolate |
| 10/03/2006 | CA2250115C Fast disintegrating oral dosage form |
| 10/03/2006 | CA2225741C Ionophore antibiotic formulations |
| 10/03/2006 | CA2215319C Compositions comprising nicotinylalanine and an inhibitor of glycine conjugation or vitamin b6 |
| 10/03/2006 | CA2213188C Treatment of vascular thrombosis and restenosis with inhaled nitric oxide |
| 09/28/2006 | WO2006102061A2 Methods of decreasing calcification |
| 09/28/2006 | WO2006101782A2 A cysteine-containing peptide tag for site-specific conjugation of proteins |
| 09/28/2006 | WO2006101487A1 Production and therapeutic uses of th1-like regulatory t cells |
| 09/28/2006 | WO2006101273A1 Prophylactic/therapeutic agent for cancer |
| 09/28/2006 | WO2006100797A1 Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen |
| 09/28/2006 | WO2006100468A1 Treatment of laminitis |
| 09/28/2006 | WO2006100213A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
| 09/28/2006 | WO2006099739A1 Use of adnf polypeptides for treating peripheral neurotoxicity |
| 09/28/2006 | WO2006060731A3 Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1 |
| 09/28/2006 | WO2006004959A3 Pegylated interferon alpha-1b |
| 09/28/2006 | WO2005094234A3 Dietary supplement for treating digestive system disorders |
| 09/28/2006 | WO2005080384A3 Benzimidazole derivative and use as aii receptor antagonist |
| 09/28/2006 | WO2005054493A3 Altered activity of toll-like receptors |
| 09/28/2006 | WO2005046659A8 Migraine treatments including isovaleramide compounds and serotonin agonists |
| 09/28/2006 | WO2004069146A3 L-dopa amide derivatives and uses thereof |
| 09/28/2006 | US20060217444 Tramadol for the treatment of functional gastrointestinal disorders |
| 09/28/2006 | US20060217433 Sulfonamide derivatives as ppar modulators |
| 09/28/2006 | US20060217429 Treating stroke or reccurence with an ACE inhibitor selected from quinapril, captropril, lisinopril, perindopril, trandolapril, enalapril, moexipril, fosinopril, ramipril, cilazapril, imidapril, spirapril, temocapril, benazepril, alacepril, ceronapril, delapril, moveltipril and trandolapril |
| 09/28/2006 | US20060217421 Fortifier |
| 09/28/2006 | US20060217413 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 09/28/2006 | US20060217395 Combinations of paroxetine and 4- (s) - (4-acetyl-piperazin-1-yl) -2- (r)- (4-fluoro-2-methyl- phenyl -piperidine-1-carboxylic acid [1- (r) (3,5-bis-trifluoromethyl-phenyl) -ethyl] methylamide for treatment of depression and / or anxiety |
| 09/28/2006 | US20060217391 Method of treating functional bowel disorders |
| 09/28/2006 | US20060217373 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 09/28/2006 | US20060217363 Methods and therapeutic combinations for the treatment of hypercholesterolemia and xanthoma using sterol absorption inhibitors |
| 09/28/2006 | US20060217351 Method for treating cardiovascular diseases |
| 09/28/2006 | US20060217315 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| 09/28/2006 | US20060216777 Immobilization on solid support |
| 09/28/2006 | US20060216755 IL1RL-1 as a cardiovascular disease marker and therapeutic target |
| 09/28/2006 | US20060216745 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 09/28/2006 | US20060216732 drug screening; identifying a therapeutic for decreasing intraocular pressure raised due to frizzled related protein (FRP) overexpression; contacting a trabecular meshwork cell expressing a Wnt pathway component or a frizzled related protein gene product with a test compound |
| 09/28/2006 | US20060216358 Such as strontium ranelate; once daily oral administration; various bone and glandular disorders |
| 09/28/2006 | US20060216341 Compositions for treating drug resistance |
| 09/28/2006 | US20060216328 Topical composition comprising a cyclofructan, a carrier and a drug |
| 09/28/2006 | US20060216289 GFRalpha3 and its uses |
| 09/28/2006 | US20060216245 Composition for local anesthesia |
| 09/28/2006 | US20060216244 Delivery of compounds for the treatment of parkinson's through an inhalation route |
| 09/28/2006 | US20060216243 Delivery of Beta-Blockers Through An Inhalation Route |
| 09/28/2006 | CA2602893A1 Use of adnf polypeptides for treating peripheral neurotoxicity |
| 09/28/2006 | CA2602374A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
| 09/28/2006 | CA2601669A1 Methods of decreasing calcification |
| 09/27/2006 | EP1705487A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 09/27/2006 | EP1704871A1 Iron supplement and utilization of the same |
| 09/27/2006 | EP1704863A2 Combination comprising N-5-4-(4-Methyl-Piperazino-Methyl-)Benzoyla Mido]-2-Methylphenyl -4-(3-Pyridyl)-2Phyrimidine-amine and a chemotherapeutic agent |
| 09/27/2006 | EP1704231A2 Ppmp as a ceramide catabolism inhibitor for cancer treatment |
| 09/27/2006 | EP1703919A1 Vaginal compositions for treating infections |
| 09/27/2006 | EP1703918A2 Combination of crf antagonists and 5-ht 1b receptor antagonists |
| 09/27/2006 | EP1703911A1 Combination therapies employing a composition comprising a hmg coa reductase inhibitor and a vitamin b6 related compound |